We inadvertently administered a 0.5 mL dose of Afluria (CSL Seqirus) to a 1-year-old child before realizing that the vaccine is only licensed for a 0.25 mL dose in children 6 months to 3 years. What should we do?

The dose does not need to be repeated. However, this is a vaccine administration error. Clinicians should carefully select an influenza vaccine and vaccine dose that is licensed for the age group of the person being vaccinated. The error should be conveyed to the child’s parent or guardian and also reported to Vaccine Adverse Events Reporting System (VAERS) at www.vaers.hhs.gov. Actions should be taken to limit vaccine administration errors at the clinic where the error occurred. Immunize.org’s educational piece “Influenza Vaccine Products for the 2023-24 Influenza Season” (available at www.immunize.org/catg.d/p4072.pdf) provides helpful information on the wide variety of influenza vaccines in use this season.